Firouz Asgarzadeh, Ph.D., is the founder of OSD Pharmaceutical Solutions LLC, a consulting firm focused on formulation and process development.

He brings nearly 30 years of global R&D and commercial leadership experience in formulation science, modified-release coatings, solubility enhancement technologies (spray drying, hot-melt extrusion), oral and injectable dosage forms, and polymer processing.

Previously, Dr. Asgarzadeh was Senior Vice President of Pharmaceutics at BioDuro, leading technical strategy and managing formulation, analytical, and process teams. He also spent over a decade as Director of Technical Services at Evonik, advancing solubility enhancement and modified-release platforms.

Earlier in his career, he held scientific roles at Merck, Catalent, and Alkermes. He earned his Ph.D. in Polymeric Materials from Université Claude Bernard, Lyon, and a master’s degree from Université Louis Pasteur (Strasbourg I), France, and Polytechnic University, Tehran, Iran.

An active contributor to AAPS, he served as Chair of the CRO and Excipient Focus Groups and Chair of the Interphex Scientific Committee in 2025.